Accenture to partner with Mujin on digital transformation of logistics
Category: #business  By Mateen Dalal  Date: 2019-06-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

Accenture to partner with Mujin on digital transformation of logistics

The companies will combine their solution and insights to improve manufacturing productivity

Accenture, a multinational services company, recently announced that it is going to collaborate with Mujin, manufacturer of industrial robot controller, in order to deliver an intelligence service which uses artificial intelligence (AI) and robotics to accelerate digital transformation in the logistics sector.

Apparently, both the companies will work together to provide services like logistics planning and implementation and operation of technology. For instance, businesses with logistics centers can implement a solution comprising of Accenture’s fulfillment service that is based on exact demand forecast and deep industry insights along with the intelligent robot controller of Mujin.

Business will reportedly be able to support visualized operational data to refine plans for logistics through the visualization and automation of warehouse operations and optimize plans for delivery to accelerate the transformation in logistics.

Citing reliable sources, end-to-end service capabilities are offered by Accenture for digital transformation and the reported collaboration with Mujin will enhance the services of AI-powered supply chain management. Mujin both develops and delivers intelligent robot controllers which automate boxing processes and picking of disordered loads, all of it based on their motion planning AI.

Both the companies will be combining their solutions and insights to improve manufacturing productivity as well as generate new value according to the clients’ business goals and right logistics strategies.

Accenture’s country managing director, Japan, Atsushi Egawa said that to accelerate transformation, the organizations need to form broader ecosystems by cooperating with external partners. Mujin is the world’s leading provider of robot technology and will play an important role in transforming manufacturing industries.

The collaboration will strengthen Accenture’s ecosystems in the robotics and the AI fields and drive transformation for clients further. Accenture will reportedly extend the initiative into the manufacturing field with an aim to optimize the entire supply, Egawa mentioned.

Issei Takino, CEO, Mujin said that the collaboration with Accenture will help their mission to generate new value in the society by providing intelligence to industrial robots and deploying them.

 

Source Credit- https://www.businesswire.com/news/home/20190627005236/en/Accenture-Mujin-Collaborate-Clients-Accelerate-Digital-Transformation

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Novo Nordisk and Medtronic team up to offer digital diabetes solutions
Novo Nordisk and Medtronic team up to offer digital diabetes solutions
By Mateen Dalal

With growing population of diabetic patients, diabetes management is becoming a daunting activity. Sugar level management and insulin injections tracking is a difficult work. Thus, leading pharmaceutical companies are collaborating with medical devic...

Akesis unveils its advanced Galaxy™ RTi and Gemini360 at ASTRO 2019
Akesis unveils its advanced Galaxy™ RTi and Gemini360 at ASTRO 2019
By Mateen Dalal

The healthcare company will showcase its drugs in the ASTRO annual meeting 2019 that could help offer improved efficiency and confidence in treatment delivery. Akesis, Inc., a hospital and healthcare company based in the U.S. that offers innovative...

Adverum reveals positive results from Phase 1 trial of ADVM-022
Adverum reveals positive results from Phase 1 trial of ADVM-022
By Mateen Dalal

The drug was well tolerated and was safe, and has shown the capacity to improve the treatment paradigm for patients with wet AMD. Adverum Biotechnologies, Inc., a company that develops medical therapies for ocular and rare diseases, recently announc...